14 articles for MJ Sheardown
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.

Ferrosan
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.

Novo Nordisk
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.

Eli Lilly
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.

Novo Nordisk
Identification of novel (isoxazole)methylene-1-azabicyclic compounds with high affinity for the central nicotinic cholinergic receptor

TBA
Synthesis and structure activity relationships of alkyl substituted analogues of the functional M
1 selective muscarinic receptor agonist xanomeline

TBA
The synthesis and biochemical evaluation of new A
1 selective adenosine receptor agonists containing 6-hydrazinopurine moieties

TBA
Synthesis and structure-activity relationships of heterocyclic analogues of the functional M
1 selective muscarinic agonist hexyloxy-TZTP

TBA
N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.

Novo Nordisk
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonists.

Eli Lilly
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.

Novo Nordisk
Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndrome.

Lilly Research Laboratories
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .

Novo Nordisk Cns Division